Kainos Medicine카이노스메드
284620 · KOSDAQ · ₩284620 · 카이노스메드
₩1,087 ₩0 (0.00%)End-of-day · Oct 27, 2026 · End-of-day prices.
Filings
- Other Market Notice (Non-Implementation of Market Measures Following Addition of Grounds for Investment Caution Designation and Non-Implementation of Procedures Following Addition of Grounds for Substantive Review of Listing Eligibility)기타시장안내 (투자주의 환기종목 지정 사유 추가 관련 시장조치 미진행 및 상장적격성 실질심사 사유 추가 관련 절차 미진행)Aug 14, 2026Open on DART
- Confirmation of Facts Such as Adverse Opinion on Semi-annual Review (Audit), Including Capital Impairment Ratio of 50% or More or Equity Under ₩1B반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)Aug 14, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Change of Head Office Location본점소재지변경Jun 16, 2026Open on DART
- Amended: Sales or supply contract terminated[기재정정]단일판매ㆍ공급계약해지May 29, 2026Open on DART
- Sales or supply contract terminated단일판매ㆍ공급계약해지May 29, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Apr 30, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 31, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 31, 2026Open on DART
- Delisting기타시장안내 ('25사업연도 감사의견 거절 관련 상장폐지 절차 미진행)Mar 23, 2026Open on DART
- Audit report submitted감사보고서제출Mar 23, 2026Open on DART
- Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 23, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 17, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 17, 2026Open on DART
- Delisting내부결산시점관리종목지정ㆍ형식적상장폐지ㆍ상장적격성실질심사사유발생Mar 16, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 16, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Jan 30, 2026Open on DART
- Other Key Management Matters (Withdrawal of Third-Party Rights Offering)기타주요경영사항 (제3자배정 유상증자 철회)Jan 23, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 23, 2026Open on DART
- Trading halt주권매매거래정지 (투자자보호)Jan 14, 2026Open on DART
- Other Market Notice (Regarding Postponement of Clearance Sale)기타시장안내 (정리매매 보류 관련)Jan 14, 2026Open on DART
- Other management matters기타경영사항(자율공시) (상장폐지결정등 효력정지 가처분신청)Jan 14, 2026Open on DART
- Delisting주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)Jan 13, 2026Open on DART
- Delisting기타시장안내 (코스닥시장위원회 개최 결과 및 상장폐지 결정 안내)Jan 13, 2026Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Jan 5, 2026Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Dec 30, 2025Open on DART
- Amended: Delisting[기재정정]기타시장안내 (상장폐지 관련 이의신청서 접수)Dec 12, 2025Open on DART
- Delisting기타시장안내 (상장폐지 관련 이의신청서 접수)Dec 12, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Dec 12, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 9, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Nov 28, 2025Open on DART
- Delisting주권매매거래정지기간변경 (상장폐지 사유 발생)Nov 21, 2025Open on DART
- Other Market Notice (Announcement of Results of Corporate Review Committee Meeting)기타시장안내 (기업심사위원회 개최 결과 안내)Nov 21, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Nov 14, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Oct 30, 2025Open on DART
- Other Market Notice (Submission of Improvement Plan)기타시장안내 (개선계획서 제출)Oct 24, 2025Open on DART
- Major management matter relevant to investors투자판단관련주요경영사항(임상시험계획승인신청등결정) (다계통위축증(MSA) 치료제 KM819의 2상 임상시험 계획 신청 승인)Oct 21, 2025Open on DART
- Trading halt주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)Sep 26, 2025Open on DART
- Other Market Notice (Decision to Subject to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상 결정)Sep 26, 2025Open on DART
- Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획변경승인신청) (다계통 위축증(MSA) 치료신약 KM-819의 임상 2상 시험계획 승인 신청)Sep 12, 2025Open on DART
- Other Market Notice (Extension of Investigation Period to Determine Whether Substantive Review Applies)기타시장안내 (실질심사 대상여부 결정을 위한 조사기간 연장 안내)Sep 5, 2025Open on DART
- Amended: Half-year report (Jun 2025)[기재정정]반기보고서 (2025.06)Sep 5, 2025Open on DART
- Amended: Quarterly report (Mar 2025)[기재정정]분기보고서 (2025.03)Sep 5, 2025Open on DART
- [Amended] Occurrence of Shortfall in Semi-Annual or Quarterly Revenue[기재정정]반기또는분기매출액미달사실발생Sep 3, 2025Open on DART
- Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 1, 2025Open on DART
- Designation as Unfaithful Disclosure Company (Disclosure Change)불성실공시법인지정 (공시변경)Aug 18, 2025Open on DART
- [Corrected] Confirmation of Facts Such as Adverse Opinion or Disclaimer in Semi-Annual Review (Audit) Report, Including Capital Impairment Ratio of 50% or More or Equity Below ₩1B[기재정정]반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)Aug 18, 2025Open on DART
- Other Market Notice (Notice on Deadline for Decision on Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상결정 기한 안내)Aug 18, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Kainos Medicine / 카이노스메드 / 284620 / KRX:284620
Source: KRX statistical information